Glucagon-like peptide-1 (GLP-1) is primarily known for its role in glucose homeostasis and food intake control, and GLP-1 analogs (either as monotherapy or dual agonists) are commonly used for Type 2 Diabetes and obesity treatment in humans. Beyond these functions, the receptor for GLP-1 (GLP-1R) is widely expressed throughout the brain, including in the hippocampus and interconnected regions that contribute to learning and memory processes. Here we review emerging evidence supporting a role for GLP-1 signaling in promoting learning and memory function, particularly in dementia and other conditions that present hippocampal dysfunction. Evidence is synthesized from preclinical rodent models revealing that GLP-1 analog treatment improves deficits in memory function and hippocampal neuronal signaling processes in various models of dementia, aging, and metabolic disruption. While findings from human clinical trials and meta-analyses also show promise for GLP-1 analog-based treatment for memory disorders, results thus far are mixed, with many studies underpowered and/or lacking comprehensive memory evaluation. We describe several distinct yet non-mutually exclusive neurobiological mechanisms via which GLP-1R signaling can enhance memory, including blood-brain barrier penetration and direct action on hippocampal GLP-1Rs, improved peripheral and central insulin sensitivity, vagus nerve GLP-1R activation, and peripheral metabolic and inflammatory improvements. We conclude by emphasizing important considerations for future clinical trials for GLP-1 analogs in the treatment of Alzheimer's and other memory disorders, including focusing on metabolically vulnerable individuals, stratifying results by cardiovascular and metabolic status, and leveraging existing GLP-1 analogs and drug delivery approaches towards maximizing bioavailability and brain penetrance.
Central dopamine (DA) is critical for food-related reinforcement learning. Here we investigated DA function in the hippocampus (HPC), a brain region associated with episodic memory, and more recently, food intake control. Results from fiber photometry recordings in rats revealed that DA binding was significantly elevated in the dorsal HPC in the post-meal relative to the pre-meal state following consumption of chow, high-fat diet, or liquid sucrose. Post-meal DA signaling elevations are dependent on nutrient consumption, as HPC DA binding levels were unaffected by consumption of a low-calorie sweetener solution or by peripheral administration of glucose or the satiation hormone, cholecystokinin. Pharmacological HPC D2R blockade impaired spatial memory for meal location and reduced the latency to initiate a subsequent meal, whereas HPD D2R agonism reduced food intake. Collective results identify HPC DA-D2R signaling as a neurobiological mechanism through which nutrient consumption promotes meal-related episodic memory formation to reduce subsequent food intake.